Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring

Haematologica. 2014 Feb;99(2):e26-7. doi: 10.3324/haematol.2013.097287.
No abstract available

Keywords: interaction; novel oral anticoagulants; pulmonary embolism.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibiotics, Antitubercular* / administration & dosage
  • Antibiotics, Antitubercular* / adverse effects
  • Antibiotics, Antitubercular* / pharmacokinetics
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Anticoagulants* / pharmacokinetics
  • Atrial Fibrillation / therapy*
  • Ciprofloxacin* / administration & dosage
  • Ciprofloxacin* / adverse effects
  • Ciprofloxacin* / pharmacokinetics
  • Coronary Artery Bypass*
  • Drug Incompatibility
  • Female
  • Humans
  • Morpholines / administration & dosage
  • Morpholines / adverse effects
  • Morpholines / pharmacokinetics
  • Rifampin* / administration & dosage
  • Rifampin* / adverse effects
  • Rifampin* / pharmacokinetics
  • Rivaroxaban
  • Thiophenes / administration & dosage
  • Thiophenes / adverse effects
  • Thiophenes / pharmacokinetics

Substances

  • Antibiotics, Antitubercular
  • Anticoagulants
  • Morpholines
  • Thiophenes
  • Ciprofloxacin
  • Rivaroxaban
  • Rifampin